AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 77 filers reported holding AKCEA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $985,000 | -59.6% | 68,847 | -52.1% | 0.02% | +78.6% |
| Q4 2019 | $2,436,000 | +574.8% | 143,775 | +513.0% | 0.01% | +366.7% |
| Q3 2019 | $361,000 | -77.6% | 23,454 | -65.9% | 0.00% | -81.2% |
| Q2 2019 | $1,611,000 | +186.7% | 68,680 | +246.2% | 0.02% | +166.7% |
| Q1 2019 | $562,000 | +38.1% | 19,839 | +46.9% | 0.01% | +20.0% |
| Q4 2018 | $407,000 | -5.6% | 13,502 | +9.8% | 0.01% | 0.0% |
| Q3 2018 | $431,000 | – | 12,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |